Market demand
Are buyers already searching for this problem?
Skip or Ship — Validate by Industry
Validate your healthtech idea with clinical and regulatory-aware scoring — MHRA pathway, data privacy, and clinical validation needs.
Are buyers already searching for this problem?
How crowded is the space for this exact outcome?
Can a focused team ship a credible first version quickly?
Is there a believable way to monetize early?
Do you know exactly who owns this pain day to day?
Healthtech sits at the intersection of two hard constraints most other categories don't face together: regulatory classification (is this a medical device requiring MHRA/CE marking, or wellness software that doesn't?) and clinical trust (will clinicians and patients actually rely on it?).
This validator checks whether your product needs medical-device classification, what clinical evidence a buyer will expect, and whether the sales motion targets clinicians, patients, or health systems — each with very different validation criteria.
| Category | What's different for Healthtech |
|---|---|
| Execution Difficulty | Medical device classification (does clinical decision-support functionality trigger MHRA/CE-mark requirements?) is checked as a core execution risk, not an afterthought. |
| Defensibility | Clinical evidence and peer-reviewed validation, once obtained, are a strong moat — competitors can't fast-follow trust built over years of clinical use. |
| Distribution | NHS/health-system procurement cycles are notoriously slow (often 12+ months); direct-to-consumer wellness products have a completely different distribution profile scored separately. |
| Real Pain | The engine distinguishes between wellness/lifestyle products (lower regulatory bar, more competition) and clinical-decision products (higher bar, but more defensible once cleared). |
| Metric | Typical value | Why it matters |
|---|---|---|
| Medical device classification threshold | Software providing diagnosis or treatment recommendations typically requires classification | Pure information/wellness apps usually don't — but the line is genuinely unclear in many cases; get regulatory advice early. |
| Typical NHS procurement cycle | 12–24 months | Budget significant runway if targeting health-system sales. |
| Direct-to-consumer wellness CAC | £30–£150 | Lower regulatory bar means more competition and correspondingly higher CAC. |
| Clinical validation study timeline | 6–18 months minimum | For products requiring peer-reviewed efficacy evidence. |
AI-assisted triage tool for GP practices with clinical validation partnership planned
Strong defensibility once validated, but regulatory pathway and NHS procurement timeline need explicit planning before Ship.
Consumer wellness app for meditation and sleep tracking, no clinical claims
Lower regulatory bar but extremely crowded category (Calm, Headspace) requiring a specific differentiated wedge.
Generic symptom checker making diagnosis claims with no medical device pathway planned
Likely triggers medical device classification with no regulatory plan — high legal and execution risk as described.
The examples above show the pattern — now score your specific idea. Head to the free idea validation tool and describe your buyer, pain, distribution channel, and pricing model. You'll get a Ship, Fix, or Skip verdict with the same 10-category breakdown in under 30 seconds.
Direct answer
The Skip or Ship Idea Lifecycle System evaluates ideas with five consistent signals: market demand, competition intensity, execution difficulty, revenue potential, and customer clarity. Same inputs, same verdict — every time.
One buyer segment with recurring pain and a clear trigger to pay now. If that is vague, validation can't fix it.
Generic ICPs, vague outcomes, and zero distribution plan. These collapse execution speed within weeks.
One channel, one wedge use case, one pricing hypothesis to test in the next 14 days.
Move from idea generation into evidence-based validation with the core Skip or Ship Idea Lifecycle System. Free verdict, premium signal cards, no signup needed for the first run.
It depends on functionality — software that provides diagnosis, treatment recommendations, or clinical decision support often requires medical device classification. Pure wellness or information apps often don't, but the boundary is genuinely unclear in many cases. Get specific regulatory advice before building.
Often 12–24 months from first conversation to signed contract. Budget significant runway and consider direct-to-consumer or private-clinic channels as faster initial paths.
Depends on the buyer — NHS trusts often expect peer-reviewed evidence or at minimum a clinical safety case; direct-to-consumer wellness buyers rarely require formal clinical evidence, though credibility signals (partnerships, testimonials) still matter.
Ready to pressure-test this idea with live market signals?
Validate your Healthtech idea